Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 26:13:2187-2195.
doi: 10.2147/JPR.S257337. eCollection 2020.

Effects of Additional Intraoperative Administration of Sufentanil on Postoperative Pain, Stress and Inflammatory Responses in Patients Undergoing Laparoscopic Myomectomy: A Double-Blind, Randomized, Placebo-Controlled Trial

Lian Liu  1 , Bingyu Li  1 , Quan Cao  2 , Bo Zhao  1 , Wenwei Gao  3 , Yuan Chen  4 , Shihua Yu  5
Affiliations

Effects of Additional Intraoperative Administration of Sufentanil on Postoperative Pain, Stress and Inflammatory Responses in Patients Undergoing Laparoscopic Myomectomy: A Double-Blind, Randomized, Placebo-Controlled Trial

Lian Liu et al. J Pain Res. .

Abstract

Purpose: Although pain after laparoscopic surgery is assumed to be minor, many women still suffer from unexpected postoperative pain. Thus, we aimed to assess whether additional intraoperative administration of sufentanil could help to improve postoperative pain and related agitation, stress, and inflammation response in patients undergoing laparoscopic myomectomy.

Patients and methods: Forty female patients with uterine myoma scheduled for laparoscopic myomectomy under general anesthesia were randomized to receive sufentanil (group T, n=20) or normal saline (group C, n=20) 1h before the end of the surgery. The postoperative pain, agitation, stress, inflammation, and adverse effects were measured.

Results: As the primary outcome, the visual analog scale (VAS) pain score was significantly reduced in group T as compared with group C at each measured time point in a post-anesthesia care unit (PACU), VAS 5 min (31.5 ± 2.7 vs 40.6 ± 5.6) (P<0.001), VAS 30 min (36.5 ± 4.5 vs 46.0 ± 2.9) (P<0.001), VAS 1h (37.8 ± 4.0 vs 48.6 ± 5.5) (P<0.001). The secondary outcomes, including the sedation agitation scale (SAS) scores, plasma concentrations of epinephrine and norepinephrine, and the levels of plasma interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-α) in group T were remarkably lower than those in group C (P < 0.001). The cough cases in group T also showed a significant reduction in comparison with group C (P < 0.05). In addition, the anesthetic recovery time, including the spontaneous breathing recovery time and extubation time, were not significantly different between the two groups, as were the cases of respiratory depression and postoperative delirium (P > 0.05).

Conclusion: For patients undergoing laparoscopic myomectomy, administration of sufentanil 1 h before the end of surgery shows excellent analgesic and sedative effects, alleviated postoperative stress and inflammatory responses, reduced incidence of cough, without prolonging anesthetic recovery time and increasing adverse reactions.

Keywords: anesthesia; laparoscopic myomectomy; postoperative outcomes; sufentanil.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Flow diagram of patient recruitment. Abbreviations: Group C, placebo control group; Group T, the sufentanil test group.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Tamrakar SR, Dongol A, Shakya S, Kayastha B. Minimal invasive gynaecological surgeries in dhulikhel hospital: one and half decade long experience. Kathmandu Univ Med J. 2018;16(64):333–337. - PubMed
    1. Stewart EA, Lytle BL, Thomas L, et al. The comparing options for management: patient-centered results for uterine fibroids (COMPARE-UF) registry: rationale and design. Am J Obstet Gynecol. 2018;219(1):95 e9195 e10. doi:10.1016/j.ajog.2018.05.004 - DOI - PMC - PubMed
    1. Lee D, Kim SK, Kim K, Lee JR, Suh CS, Kim SH. Advantages of single-port laparoscopic myomectomy compared with conventional laparoscopic myomectomy: a randomized controlled study. J Minim Invasive Gynecol. 2018;25(1):124–132. doi:10.1016/j.jmig.2017.08.651 - DOI - PubMed
    1. Vargas MV, Larson KD, Sparks A, et al. Association of operative time with outcomes in minimally invasive and abdominal myomectomy. Fertil Steril. 2019;111(6):1252–1258 e1251. doi:10.1016/j.fertnstert.2019.02.020 - DOI - PubMed
    1. Vargas MV, Robinson JK, Schwab TD, Opoku-Anane J, Marfori CQ, Moawad GN. Feasibility and safety of a minimally invasive surgical (MIS) approach in complex myomectomies. J Minim Invasive Gynecol. 2015;22(6S):S38. doi:10.1016/j.jmig.2015.08.106 - DOI - PubMed